These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8866710)

  • 21. Novel opiate binding sites selective for benzomorphan drugs.
    Chang KJ; Hazum E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4141-5. PubMed ID: 6270660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.
    Kazmi SM; Mishra RK
    Mol Pharmacol; 1987 Jul; 32(1):109-18. PubMed ID: 3037297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence in neuroblastoma cells of a mu 3 receptor with selectivity for opiate alkaloids but without affinity for opioid peptides.
    Cruciani RA; Dvorkin B; Klinger HP; Makman MH
    Brain Res; 1994 Dec; 667(2):229-37. PubMed ID: 7697360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevation of naloxone-sensitive 3H-dihydromorphine binding in hippocampal formation of genetically epilepsy-prone rats.
    Savage DD; Mills SA; Jobe PC; Reigel CE
    Life Sci; 1988; 43(3):239-46. PubMed ID: 2840539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid receptor-mediated responses in the dentate gyrus and CA1 region of the rat hippocampus.
    Neumaier JF; Mailheau S; Chavkin C
    J Pharmacol Exp Ther; 1988 Feb; 244(2):564-70. PubMed ID: 2894454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opposing effects of oxytocin and of a mu-receptor agonistic opioid peptide on the same class of non-pyramidal neurones in rat hippocampus.
    Raggenbass M; Wuarin JP; Gähwiler BH; Dreifuss JJ
    Brain Res; 1985 Oct; 344(2):392-6. PubMed ID: 2994843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus.
    Pandis C; Sotiriou E; Kouvaras E; Asprodini E; Papatheodoropoulos C; Angelatou F
    Neuroscience; 2006 Jun; 140(1):163-75. PubMed ID: 16542781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
    Rahmani NH; Gulati A; Bhargava HN
    Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Light microscopic autoradiographic localization of delta opioid receptors in the rat brain using a highly selective bis-penicillamine cyclic enkephalin analog.
    Gulya K; Gehlert DR; Wamsley JK; Mosberg H; Hruby VJ; Yamamura HI
    J Pharmacol Exp Ther; 1986 Aug; 238(2):720-6. PubMed ID: 3016247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mu opioid receptors participate in the excitatory effect of opiates in the hippocampal slice.
    Bostock E; Dingledine R; Xu G; Chang KJ
    J Pharmacol Exp Ther; 1984 Dec; 231(3):512-7. PubMed ID: 6094789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
    Chang KJ; Hazum E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visualization of muscarinic receptor-mediated phosphoinositide turnover in the hippocampus of young and aged, learning-impaired Long Evans rats.
    Nicolle MM; Gallagher M; McKinney M
    Hippocampus; 2001; 11(6):741-6. PubMed ID: 11811668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opiate receptor binding characteristics of dimeric analogues of mu-selective DAGO-enkephalin.
    Shimohigashi Y; Waki M; Izumiya N; Costa T; Herz A; Kurono M; Yagi K
    Biochem Int; 1986 Aug; 13(2):199-203. PubMed ID: 3021160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment.
    Tao PL; Law PY; Loh HH
    J Pharmacol Exp Ther; 1987 Mar; 240(3):809-16. PubMed ID: 3031275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of naloxone-sensitive [3H]dihydromorphine binding sites within the hippocampus of the rat.
    Meibach RC; Maayani S
    Eur J Pharmacol; 1980 Nov; 68(2):175-9. PubMed ID: 6258927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetyl-L-carnitine reduces the age-dependent loss of glucocorticoid receptors in the rat hippocampus: an autoradiographic study.
    Patacchioli FR; Amenta F; Ramacci MT; Taglialatela G; Maccari S; Angelucci L
    J Neurosci Res; 1989 Aug; 23(4):462-6. PubMed ID: 2769802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naltrexone-induced opiate receptor supersensitivity.
    Zukin RS; Sugarman JR; Fitz-Syage ML; Gardner EL; Zukin SR; Gintzler AR
    Brain Res; 1982 Aug; 245(2):285-92. PubMed ID: 6289965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cystamine-enkephalin dimer. Syntheses and biological activities of enkephalin analogs containing cystamine and cysteamine.
    Kondo M; Kodama H; Costa T; Shimohigashi Y
    Int J Pept Protein Res; 1986 Feb; 27(2):153-9. PubMed ID: 3009340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of kappa opiate receptors in rat spinal cord-dorsal root ganglion cocultures and their regulation by chronic opiate treatment.
    Attali B; Vogel Z
    Brain Res; 1990 May; 517(1-2):182-8. PubMed ID: 2165432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats.
    Pfeiffer A; Feuerstein G; Kopin IJ; Faden AI
    J Pharmacol Exp Ther; 1983 Jun; 225(3):735-41. PubMed ID: 6306217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.